Carberry Christine A. 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Apr 20, 2018
Insider Transaction Report
Form 4
Carberry Christine A.
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-04-18$4.83/sh−2,026$9,786→ 115,176 total
Footnotes (2)
- [F1]Sale of a total of 2,026 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 7,084 shares of restricted stock on April 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 90,832 shares of restricted stock.